Barclays Downgrades NuVasive (NUVA) to Equalweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
JMP Securities Downgrades NuVasive (NUVA) to Market Perform
October 4, 2012 2:58 PM EDTJMP Securities downgraded NuVasive (NASDAQ: NUVA) from Market Outperform to Market Perform after the company's third quarter warning.
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $22.62 yesterday, with a 52 week range of $11.02-$25.99.... More
Wells Fargo Downgrades NuVasive (NUVA) to Market Perform after Warning
October 4, 2012 9:59 AM EDTWells Fargo downgraded NuVasive (NASDAQ: NUVA) from Outperform to Market Perform and slashed their price target from $29-$31 to $15-$16 after last night's warning.
"Our sense is that these issues are likely NUVA specific, rather than industry-wide problems, and are consistent... More
First Analysis Downgrades NuVasive (NUVA) to Equal Weight after Warning
October 4, 2012 9:47 AM EDTFirst Analysis downgraded NuVasive (NASDAQ: NUVA) from Overweight to Equal Weight after last night's warning.
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $22.62 yesterday, with a 52 week range of $11.02-$25.99.... More
Summer Street Downgrades NuVasive (NUVA) to Neutral
October 4, 2012 9:46 AM EDTSummer Street downgraded NuVasive (NASDAQ: NUVA) from Buy to Neutral.
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $22.62 yesterday, with a 52 week range of $11.02-$25.99.... More
Brean Murray Carret & Co. Downgrades NuVasive (NUVA) to Hold on Warning; Globus (GMED), Orthofix (OFIX) Benefit
October 4, 2012 7:04 AM EDTBrean Murray Carret & Co. downgraded NuVasive (NASDAQ: NUVA) from Buy to Hold after last night's warning.
"The miss was due to weakness in the core US Lumbar business (IOM was also weak), but it had less to do with the competitive... More
RBC Capital Downgrades NuVasive (NUVA) to Underperform
October 4, 2012 6:56 AM EDTRBC Capital downgraded NuVasive (NASDAQ: NUVA) from Outperform to Underperform with a price target of $16.00 (from $25.00) after the Q3 warning after the close.
For an analyst... More
BMO Capital Downgrades NuVasive (NUVA) to Underperform after Warning
October 4, 2012 6:54 AM EDTBMO Capital downgraded NuVasive (NASDAQ: NUVA) from Market Perform to Underperform with a price target of $15.00 (from $23.00), after the Q3 warning after the close.
For an... More
NuVasive (NUVA) Guides Q3 Revenues Lower
October 3, 2012 4:07 PM EDTNuVasive, Inc. (NASDAQ: NUVA) announced preliminary unaudited information regarding expected revenue results for the third quarter 2012, which was below its prior views and the Wall Street consensus.
NuVasive anticipates revenue for the third quarter 2012 to be approximately $147 million, which is below the Company's... More
